Evidence map›Paper›PMID 39881715›Full record

ArticleFrontiers in veterinary science2024

Assessing the detection and interaction of

Guilherme Cezar, Fernando L Leite, Eduardo Fano, Reid Phillips, John Waddell, Kate Dion, Edison Magalhães, Giovani Trevisan, Gustavo Silva, Daniel C Linhares

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guilherme CezarDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.
Fernando L LeiteBoehringer Ingelheim Animal Health USA Inc., Duluth, GA, United States.
Eduardo FanoDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.
Reid PhillipsBoehringer Ingelheim Animal Health USA Inc., Duluth, GA, United States.
John WaddellBoehringer Ingelheim Animal Health USA Inc., Duluth, GA, United States.
Kate DionDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.
Edison MagalhãesDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.
Giovani TrevisanDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.
Gustavo SilvaDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.
Daniel C LinharesDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Effective disease management strategies are essential for achieving optimal pig performance, ensuring high-quality animal health and welfare, and maintaining the economic viability of swine systems. Thus, understanding factors that lead to more or less severe disease are critically important. Porcine circovirus type 2 (PCV2) and Methodology: This observational field study involved batches of growing pigs from PRRSV-stable or PRRSV-negative sow farms. Oral fluids were collected longitudinally from weaning until market age, and tested using quantitative PCR for each of the aforementioned pathogens. The study included 36 batches with a total of 46,446 growing pigs, resulting in 4,000 oral fluid samples. Then, batches were categorized based on key performance indicators (mortality and average daily gain), PRRSV detection timing and total genomic copies of each pathogen. Results: Nineteen groups were characterized as high-performance and seventeen as low-performance. Mortality ranged from 5 to 9% in high-performance groups and 10.3-20.9% in low-performance groups. Average daily gain ranged from 0.68-0.86 kg in high-performance groups and 0.63-0.81 kg in low-performance groups. Discussion: This study expanded our understanding of PRRSV, PCV2, and

Indexed as

average daily gainco-detectionLawsonia intracellularismortalityoral fluidpathogenPCV2PRRSV

Identifiers

PMID39881715
PMCPMC11776293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.